Stock Screener App

Gratuito -

Installare

Diagnostics & Research

99.45

3.45% 3.32

after-market

Dopo l'orario di chiusura: 99.45

Revvity Inc (RVTY)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché RVTY Giù? Forum Previsione Frazionamento azionario Storia dei dividendi

Revvity Inc Borsa (RVTY) Ultime notizie

What drives Revvity Inc. stock priceHigh-yield capital appreciation - Autocar Professional

Wall Street's Insights Into Key Metrics Ahead of Revvity (RVTY) Q2 Earnings - Yahoo Finance

What analysts say about Revvity Inc. stockFree Popular Stock Recommendations - Autocar Professional

Revvity Inc. Stock Analysis and ForecastRobust investment performance - jammulinksnews.com

Investors Interested In Revvity, Inc.'s (NYSE:RVTY) Earnings - simplywall.st

Is Revvity Inc. a good long term investmentAccelerated investment success - Autocar Professional

Revvity (RVTY) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - Yahoo Finance

Thermo Fisher, Exact Sciences, Integer Holdings, Revvity, and 10x Genomics Shares Are Falling, What You Need To Know - TradingView

How the (RVTY) price action is used to our Advantage - news.stocktradersdaily.com

Earnings Preview: What to Expect From Revvity's Report - MSN

YieldBoost Revvity To 8.9% Using Options - Nasdaq

Ex-Dividend Reminder: Williams Sonoma, Revvity and Zoetis - Nasdaq

Revvity, Inc. Q2 2025 Earnings Preview: Market Expectations and PredictionsNews and Statistics - IndexBox

Revvity Dividend and Company Updates: Key Insights Before Jul 18, 2025 - AInvest

Revvity Inc. Stock Slides 3.0%, Underperforms Market - 富途牛牛

Earnings Preview: What To Expect From Revvity's Report - Barchart.com

Reflecting On Research Tools & Consumables Stocks’ Q1 Earnings: Revvity (NYSE:RVTY) - Yahoo Finance

Revvity (RVTY) Shares Soar 1.98% on Clinical Trial Success - AInvest

Evercore ISI Adjusts Price Target on Revvity to $115 From $116, Maintains Outperform Rating - MarketScreener

(RVTY) Trading Advice - news.stocktradersdaily.com

Revvity to Hold Earnings Call on Monday, July 28, 2025 - Business Wire

Should You Investigate Revvity, Inc. (NYSE:RVTY) At US$101? - simplywall.st

5 Insightful Analyst Questions From Revvity’s Q1 Earnings Call - Yahoo Finance

What 9 Analyst Ratings Have To Say About Revvity - Benzinga

Barclays Keeps Their Buy Rating on Revvity (RVTY) - The Globe and Mail

Is Revvity Stock Underperforming the Dow? - MSN

Is Revvity Stock Underperforming the Dow? A Case for Undervaluation and Growth - AInvest

Leerink Partners Adjusts Price Target on Revvity to $130 From $135, Maintains Outperform Rating - MarketScreener

An Intrinsic Calculation For Revvity, Inc. (NYSE:RVTY) Suggests It's 39% Undervalued - Yahoo Finance

Revvity Inc. stock outperforms competitors despite losses on the day - MarketWatch

How To Trade (RVTY) - news.stocktradersdaily.com

Are Revvity, Inc.'s (NYSE:RVTY) Mixed Financials Driving The Negative Sentiment? - simplywall.st

Revvity introduces new IVD reference standards for monitoring oncology diagnostic testing workflows - SelectScience

Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch

Revvity at Goldman Sachs Conference: Diagnostics and Software Focus By Investing.com - Investing.com Canada

Revvity at Goldman Sachs Conference: Diagnostics and Software Focus - Investing.com

Transcript : Revvity, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener

Revvity To Present At Goldman Sachs Global Healthcare Conference; Webcast At 8:00 AM ET - Nasdaq

Wellington Management Group LLP Has $743,000 Stock Holdings in Revvity, Inc. (NYSE:RVTY) - Defense World

WAT

$295.63

2.84%

NTRA

$137.82

1.50%

DGX

$170.48

4.35%

LH

$250.51

0.62%

MTD

$1,257.20

3.14%

IQV

$194.24

3.66%

Apri su Yahoo | Apri su Google | Aperto in Finviz | Apri in MarketWatch | Aperto a EDGAR | Aperto su Reuters